Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A C Cree

Showing results (11-20 of 191) with videos related to

Pageof 20
Sort By:
Annals of Neurology|September 7, 2010
Natalizumab dosage suspension: are we helping or hurting?Timothy W West, Bruce A C Cree
Neurology|December 29, 2005
Acute transverse myelitis: is the "idiopathic" form vanishing?Bruce A C Cree, Dean M Wingerchuk
JAMA Neurology|January 8, 2014
Disease activity free status: a new end point for a new era in multiple sclerosis clinical research?Carolyn J Bevan, Bruce A C Cree
Current Opinion in Neurology|April 9, 2016
Steering through complexity: management approaches in multiple sclerosisBruce A C Cree, Hans-Peter Hartung
Annals of Neurology|June 29, 2019
Reply to "Silent Progression or Bout Onset Progressive Multiple Sclerosis?"Bruce A C Cree, Stephen L Hauser
The American Journal of Medicine|July 20, 2020
Treatment of Multiple Sclerosis: A ReviewStephen L Hauser, Bruce A C Cree
General Hospital Psychiatry|November 30, 2010
Neuromyelitis optica, psychiatric symptoms and primary polydipsia: a case reportJosh Woolley, Vanja C Douglas, Bruce A C Cree
Current Opinion in Neurology|April 16, 2019
Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigmBruce A C Cree, Jan Mares, Hans-Peter Hartung
Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2015
Simultaneous serum aquaporin-4 antibody and CSF NMDA receptor antibody-positive encephalitisJames P Orengo, Melike Pekmezci, Bruce A C Cree
Current Opinion in Neurology|June 8, 2022
New drugs for multiple sclerosis: new treatment algorithmsBruce A C Cree, Hans-Peter Hartung, Michael Barnett
Pageof 20

Showing results (11-20 of 191) with videos related to

Sort By:
Pageof 20
Annals of Neurology|September 7, 2010
Natalizumab dosage suspension: are we helping or hurting?Timothy W West, Bruce A C Cree
Neurology|December 29, 2005
Acute transverse myelitis: is the "idiopathic" form vanishing?Bruce A C Cree, Dean M Wingerchuk
JAMA Neurology|January 8, 2014
Disease activity free status: a new end point for a new era in multiple sclerosis clinical research?Carolyn J Bevan, Bruce A C Cree
Current Opinion in Neurology|April 9, 2016
Steering through complexity: management approaches in multiple sclerosisBruce A C Cree, Hans-Peter Hartung
Annals of Neurology|June 29, 2019
Reply to "Silent Progression or Bout Onset Progressive Multiple Sclerosis?"Bruce A C Cree, Stephen L Hauser
The American Journal of Medicine|July 20, 2020
Treatment of Multiple Sclerosis: A ReviewStephen L Hauser, Bruce A C Cree
General Hospital Psychiatry|November 30, 2010
Neuromyelitis optica, psychiatric symptoms and primary polydipsia: a case reportJosh Woolley, Vanja C Douglas, Bruce A C Cree
Current Opinion in Neurology|April 16, 2019
Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigmBruce A C Cree, Jan Mares, Hans-Peter Hartung
Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2015
Simultaneous serum aquaporin-4 antibody and CSF NMDA receptor antibody-positive encephalitisJames P Orengo, Melike Pekmezci, Bruce A C Cree
Current Opinion in Neurology|June 8, 2022
New drugs for multiple sclerosis: new treatment algorithmsBruce A C Cree, Hans-Peter Hartung, Michael Barnett
Pageof 20